The back cover picture shows how the branched cell-penetrating peptide (CPP), na
mely (sC18)
2, effectively enters cancerous cells. Owing to its structural properties, different interactions between cancerous
and noncancerous cells occur, leading to obvious different entry pathways. As a result, (sC18)
2 strongly affects cancerous cells
and exhibits significant toxic activity to a wide range of different cancer cell types. Moreover, synergistic effects were obtained when co
mbining the CPP with the cytostatic drug actino
mycin D. More infor
mation can be found in the Full Paper by Ines Neundorf et al. on
page 42 in Issue 1, 2017 (DOI:
mdc.201600498" rel="references:https://doi.org/10.1002/cmdc.201600498">10.1002/cmdc.201600498).